225 related articles for article (PubMed ID: 27790848)
21. A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis.
Okuma K; Mitsuishi K; Hasegawa T; Tsuchihashi H; Ogawa H; Ikeda S
Ther Apher Dial; 2007 Oct; 11(5):387-90. PubMed ID: 17845399
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte apheresis for pouchitis with arthritis and pyoderma gangrenosum after restorative proctocolectomy for ulcerative colitis: a case report.
Yanaru-Fujisawa R; Matsumoto T; Nakamura S; Kochi S; Iida M; Kohda F; Hirahashi M; Yao T; Mibu R
Inflamm Bowel Dis; 2005 Aug; 11(8):780-1. PubMed ID: 16043996
[No Abstract] [Full Text] [Related]
23. Clinical management of pyoderma gangrenosum.
Wollina U
Am J Clin Dermatol; 2002; 3(3):149-58. PubMed ID: 11978136
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte and monocyte adsorption apheresis for cutaneous allergic vasculitis.
Kanekura T; Yoshii N; Kawahara K; Maruyama I; Kanzaki T
Ther Apher Dial; 2006 Jun; 10(3):287-90. PubMed ID: 16817796
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis.
Fujisawa T; Tawada C; Mizutani Y; Doi T; Yoshida S; Ogura S; Seishima M
Ther Apher Dial; 2014 Jun; 18(3):238-43. PubMed ID: 24965289
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils.
Kanekura T; Hiraishi K; Kawahara K; Maruyama I; Kanzaki T
Ther Apher Dial; 2006 Jun; 10(3):247-56. PubMed ID: 16817789
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis.
Ikeda K; Hamada T; Otsuka M; Iwatsuki K
Eur J Dermatol; 2011; 21(5):804-5. PubMed ID: 21752760
[No Abstract] [Full Text] [Related]
28. Evaluation of the efficacy of granulocyte and monocyte adsorption apheresis on skin manifestation and joint symptoms of patients with pustulotic arthro-osteitis.
Kawakami H; Nagaoka Y; Hirano H; Matsumoto Y; Abe N; Tsuboi R; Kanno Y; Okubo Y
J Dermatol; 2019 Feb; 46(2):144-148. PubMed ID: 30549087
[TBL] [Abstract][Full Text] [Related]
29. Therapy Insight: pyoderma gangrenosum-old disease, new management.
Campbell S; Cripps S; Jewell DP
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):587-94. PubMed ID: 16327838
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis.
Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
Ther Apher Dial; 2008 Feb; 12(1):13-8. PubMed ID: 18257807
[TBL] [Abstract][Full Text] [Related]
31. Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19.
Kanekura T; Kawahara K
Int J Infect Dis; 2020 Oct; 99():1-2. PubMed ID: 32721534
[TBL] [Abstract][Full Text] [Related]
32. Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.
Yamaguchi Y; Yanagi T; Sato K; Yoshimoto N; Hirata Y; Ujiie I; Nishimura M; Natsuga K; Shiiya C; Tsukinaga I; Shimizu H
J Dermatol; 2018 Apr; 45(4):483-486. PubMed ID: 29235669
[TBL] [Abstract][Full Text] [Related]
33. Three cases of subcorneal pustular dermatosis with immunohistochemical examinations.
Kishimoto M; Komine M; Okada H; Sato A; Kamiya K; Maekawa T; Murata S; Ohtsuki M
J Dermatol; 2023 Sep; 50(9):1150-1155. PubMed ID: 37288510
[TBL] [Abstract][Full Text] [Related]
34. Tracheobronchial pulmonary disease associated with pyoderma gangrenosum.
Kanoh S; Kobayashi H; Sato K; Motoyoshi K; Aida S
Mayo Clin Proc; 2009 Jun; 84(6):555-7. PubMed ID: 19483173
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis.
Kanekura T; Mochitomi Y; Fujimoto S; Kawahara K; Maruyama I; Kanzaki T
J Am Acad Dermatol; 2005 Jun; 52(6):1108-9. PubMed ID: 15928646
[No Abstract] [Full Text] [Related]
36. Granulocyte and monocyte adsorptive apheresis in the management of ulcerative colitis.
Yamamoto T
Aliment Pharmacol Ther; 2011 Jan; 33(2):288; author reply 289. PubMed ID: 21155856
[No Abstract] [Full Text] [Related]
37. Immunosuppressant and infliximab-resistant generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis.
Furusawa K; Hasegawa T; Ikeda S
Ther Apher Dial; 2012 Aug; 16(4):379-80. PubMed ID: 22817129
[No Abstract] [Full Text] [Related]
38. Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease.
Tanida S; Mizoshita T; Ozeki K; Katano T; Tanaka M; Nishie H; Shimura T; Okamoto Y; Kubota E; Kataoka H; Joh T
Ther Apher Dial; 2018 Jun; 22(3):295-300. PubMed ID: 29790276
[TBL] [Abstract][Full Text] [Related]
39. Generalized Pustular Psoriasis With IL-36 Receptor Antagonist Mutation Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis Accompanied by Reduced Serum IL-6 Level.
Fujii A; Ohnishi H; Seishima M
Ther Apher Dial; 2018 Feb; 22(1):92-93. PubMed ID: 28913961
[No Abstract] [Full Text] [Related]
40. Successful treatment of plaque-type psoriasis by granulocyte and monocyte adsorption apheresis in a patient with psoriatic arthritis.
Matsuoka A; Higashi Y; Kanekura T
J Dermatol; 2018 Nov; 45(11):e324-e325. PubMed ID: 29740866
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
